19:50 EST Aptevo Therapeutics (APVO) trading halted, news pending
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APVO:
- Aptevo Therapeutics announces 1-for-37 reverse stock split
- Biotech Alert: Searches spiking for these stocks today
- Aptevo Therapeutics highlights potential of portfolio in cancer immunotherapy
- Aptevo announces ALG.APV-527 meets trial endpoints in Phase 1 study
- Aptevo Therapeutics reports Q3 EPS (48c) vs. ($22.16) last year